Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acids
- 3 September 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (17) , 2121-2126
- https://doi.org/10.1016/0960-894x(96)00383-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Chapter 17. Recent Advancements in the Discovery and Development of Agents for the Treatment of Diabetes.Published by Elsevier ,1995
- Diabetes, Exercise, and AtherosclerosisDiabetes Care, 1992
- Diabetes mellitus and hypertension.Hypertension, 1992
- Hyperinsulinemia: possible role in obesity-induced hypertension.Hypertension, 1992
- Chapter 23. Recent Advances in the Discovery and Development of Potential Antidiabetic Agents.Published by Elsevier ,1992
- Chapter 22 New Approaches to DiabetesPublished by Elsevier ,1990
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Sulphonylureas and hypoglycaemiaBMJ, 1988
- Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agentDiabetes, 1983
- Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982